Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan

Rheumatoid arthritis (RA) is a chronic inflammatory systemic disease characterized by persistent joint synovial inflammation and swelling, leading to cartilage damage and bone erosion. This retrospective, longitudinal study is to evaluate the treatment patterns of biologic-naïve RA patients receivin...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ko-Jen Li, Chia-Li Chang, Chih-Yi Hsin, Chao-Hsiun Tang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-07-01
Edice:	Frontiers in Pharmacology
Témata:	biologic disease-modifying antirheumatic drug treatment pattern rheumatoid arthritis tofacitinib tumor necrosis factor inhibitors
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2021.628548/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!